Evidence map›Paper›PMID 29542288›Full record

Observational studyJournal of diabetes investigation2018

Non-high-density lipoprotein cholesterol is more informative than traditional cholesterol indices in predicting diabetes risk for women with normal glucose tolerance.

Lu Liu, Qiu Li, Zhongshang Yuan, Meng Zhao, Xu Zhang, Haiqing Zhang, Dongmei Zheng, Jin Xu, Ling Gao, Qingbo Guan and 5 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Journal of diabetes investigation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 2 countries.

Lu LiuDepartment of Endocrinology, Shandong Provincial Hospital affiliated to Shandong University, Jinan, China.
Qiu LiDepartment of Endocrinology, Shandong Provincial Hospital affiliated to Shandong University, Jinan, China.
Zhongshang YuanDepartment of Epidemiology and Biostatistics, School of Public Health, Shandong University, Jinan, China.
Meng ZhaoDepartment of Endocrinology, Shandong Provincial Hospital affiliated to Shandong University, Jinan, China.
Xu ZhangDepartment of Endocrinology, Shandong Provincial Hospital affiliated to Shandong University, Jinan, China.
Haiqing ZhangDepartment of Endocrinology, Shandong Provincial Hospital affiliated to Shandong University, Jinan, China.
Dongmei ZhengDepartment of Endocrinology, Shandong Provincial Hospital affiliated to Shandong University, Jinan, China.
Jin XuDepartment of Endocrinology, Shandong Provincial Hospital affiliated to Shandong University, Jinan, China.
Ling GaoShandong Clinical Medical Center of Endocrinology and Metabolism, Jinan, China.
Qingbo GuanDepartment of Endocrinology, Shandong Provincial Hospital affiliated to Shandong University, Jinan, China.
Jiajun ZhaoDepartment of Endocrinology, Shandong Provincial Hospital affiliated to Shandong University, Jinan, China.
Christopher G ProudNutrition and Metabolism, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.
Xuemin WangNutrition and Metabolism, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.
Xu HouDepartment of Endocrinology, Shandong Provincial Hospital affiliated to Shandong University, Jinan, China.ORCID http://orcid.org/0000-0002-9884-584X
REACTION Study Group
Shandong University · CNSouth Australian Health and Medical Research Institute · AU

Funding

Chinese Society of Endocrinology and National Clinical Research Center for Metabolic Diseases 2013BAI09B13Key Research an Development of Shandong Province 2017CXGC1214National Key New Drug Creation and Manufacturing Program of Ministry of Science and Technology 2012ZX09303006-001National Key Research and Development Program of China 2017YFC0909600National Key Research and Development Program of China 2017YFC1309800
6 · The paper itself

Abstract

AIMS/

introductionLimited data are available regarding the performance of non-high-density lipoprotein cholesterol (non-HDL) in predicting incident diabetes. We aimed to analyze the association between non-HDL and development of diabetes, and to estimate the cut-off point of non-HDL for discriminating incident diabetes in people with normal glucose tolerance. MATERIALS AND

methodsOf 3,653 middle-aged and elderly Chinese with normal glucose tolerance at enrollment, 1,025 men and 1,805 women returned to the 3-year follow up and were involved in the final analysis. Logistic regression analysis was used to test the association between cholesterol indices and incident diabetes, and receiver operating characteristic analyses were used to identify the optimal cut-off of each cholesterol variable for incident diabetes.

resultsNon-HDL was an independent risk factor for diabetes for women, but not for men. In women, a 1-standard deviation increment in non-HDL was associated with a 1.43-fold higher risk of diabetes (95% confidence interval 1.14-1.79; P = 0.002), whereas odds ratios for total cholesterol and low-density lipoprotein cholesterol were 1.33 (95% confidence interval 1.06-1.67; P = 0.015) and 1.30 (95% confidence interval 1.04-1.64; P = 0.024), respectively. The discriminatory power and the optimal cut-off value of non-HDL for incident diabetes increased across body mass index categories. For women with obesity, the threshold of non-HDL for screening of diabetes was estimated as 3.51 mmol/L.

conclusionsNon-HDL had better performance than traditional cholesterol indices in predicting diabetes in women, but not in men. A body mass index-specific threshold value for a non-HDL-controlling target is required in the prevention of type 2 diabetes.

Indexed as

CholesterolDiabetes MellitusFemaleHumansLipoproteinsMaleMiddle AgedProspective StudiesRisk FactorsROC CurveCholesterollipoprotein cholesterolLipoproteinsNon-high-density lipoprotein cholesterolPrimary preventionType 2 diabetes

Identifiers

PMID29542288
PMCPMC6215933
OpenAlexW2791310330

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.